Learn More
Medchemexpress LLC DX3-213B | 2749555-66-4 | 99.7% | C20H28F2N2O5S2 | 100 MG

Supplier: Medchemexpress LLC HY144310100MG
DX3-213B is a highly potent, orally active oxidative phosphorylation (OXPHOS) complex I inhibitor with an IC50 of 3.6 nM. It effectively impairs ATP generation with an IC50 of 11 nM and blocks the growth of MIA PaCa-2 cells, also with a GI50 of 11 nM. This compound is utilized in research concerning pancreatic cancer.
- Highly potent and orally active.
- Functions as an oxidative phosphorylation (OXPHOS) complex I inhibitor.
- Impairs ATP generation.
- Blocks MIA PaCa-2 cell growth.
- Used in pancreatic cancer research.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.